Global Glucose Monitoring Devices Patent Landscape Report 2024

Global Glucose Monitoring Devices Market Size

The global glucose monitoring devices market was valued at USD 16.21 billion in 2023. It is expected to grow at a CAGR of 10.4% during the forecast period of 2024-2032 and attain a market value of USD 39.49 billion by 2032.

The market value is driven by the increasing prevalence of diabetes across the globe. The growing technological advancements in modern glucose monitoring devices are boosting the number of patent applications in the industry. 

Patent Landscape Report Coverage

The Global Glucose Monitoring Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for glucose monitoring devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with glucose monitoring devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within glucose monitoring device technologies.

Key Inclusions

• Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for glucose monitoring device technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with glucose monitoring devices.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for glucose monitoring devices and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for glucose monitoring devices and their relative value in the IP are covered in the final report.

Glucose Monitoring Devices Patent Outlook

• The market is expanding due to technological advancements like non-invasive glucose monitoring devices and continuous glucose monitoring (CGM) systems. These developments improve diabetes management by providing patients with more precise, practical, and easy-to-use options. More users are also being drawn in by improved features like integration with mobile apps and real-time data sharing. Such factors are boosting the number of patent applications for these devices.

• The market is expanding because of growing awareness around the value of early diabetes diagnosis and preventative healthcare. Regular glucose monitoring is encouraged by public health campaigns and educational initiatives to prevent complications related to diabetes.

• The market for glucose monitoring devices is expanding due to government funding and supportive policies for diabetes research and management. To make glucose monitoring devices more accessible, several governments are funding the infrastructure of the healthcare industry and providing financial subsidies for them. These programs seek to enhance patient outcomes and lessen the cost of diabetes care.

What are Glucose Monitoring Devices?

Glucose monitoring devices are made to create the ideal conditions for tissue repair, thereby accelerating the healing of both acute and chronic wounds. The components of glucose monitoring devices include self-monitoring blood glucose devices and continuous glucose monitoring devices. Self-monitoring blood glucose devices are portable instruments that people can use to measure their own blood sugar levels on a regular basis. These devices offer real-time feedback to support efficient diabetes management and educate users about treatment options and lifestyle modifications.

Glucose Monitoring Devices Industry Growth Drivers

Increasing Technological Advancement is Expected to Boost the Patent Industry Growth

The accuracy, accessibility, and convenience of glucose monitoring devices have been greatly improved by technological advancements. The emphasis on better management of diabetes and improved patient outcomes are being brought by these developments. For instance, Abbott introduced the FreeStyle Libre 3 system, a noteworthy development in continuous glucose monitoring technology. It is the smallest, thinnest, and most precise CGM sensor to date and provides real-time glucose readings. Improved connectivity is another feature of the FreeStyle Libre 3 system that makes it possible for data to be easily integrated with mobile apps and other digital health platforms. This shows how technological developments are propelling the market for glucose monitoring devices. Moreover, patents covering these technologies are crucial for companies and thus impact the glucose monitoring device patent landscape positively. In 2022, there were 6,980 patent grants which increased to 7,285 by 2023.

Increasing Prevalence of Diabetes is Expected to Propel Glucose Monitoring Devices Patent Industry 

The market for glucose monitoring devices is largely driven by the increasing prevalence of diabetes worldwide. The need for dependable and easily accessible glucose monitoring solutions is growing as more people receive diabetes diagnoses, underscoring the need for these devices.

Glucose Monitoring Devices Patent Segmentation

The report will cover the following sections in detail:

Analysis by Product Type

• Self-Monitoring Blood Glucose Devices
  • Glucose Strips
  • Blood Glucose Meter
  • Lancets & Lancing Devices

• Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters and Receiver
  • Others

Analysis by Indication

• Type-1 Diabetes

• Type-2 Diabetes

Glucose Monitoring Devices Patent Segmentation Analysis

The breakup based on product type includes diagnostic monitoring devices and therapeutic monitoring devices. Diagnostic monitoring devices are used to track important health parameters continuously or sporadically to identify and treat diseases. These are specifically designed to measure blood glucose levels and provide real-time data on a patient's glucose levels to help manage diabetes.

Detailed technological data will be provided for all specified segments classified in this report.

Glucose Monitoring Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for glucose monitoring device patents, having around 240,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

 
Patent Profile of Key Companies

Among the players with glucose monitoring devices patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the glucose monitoring devices field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Genentech Inc

Founded in 1976, Genentech Inc. is a top biotechnology company with its main office located in San Francisco, California. It is well known for its cutting-edge treatments in immunology, oncology, and other fields.

Dexcom Inc

Established in 1999, Dexcom Inc. is a leader in the field of continuous glucose monitoring (CGM) devices. Dexcom, with its headquarters in San Diego, California, creates and produces cutting-edge tools to improve diabetes management for users.

Other companies include Medtronic Minimed Inc., Samsung Electronics Co. Ltd, Abbott, F. Hoffmann La Roche, Massachusetts Inst Technology, Amgen Inc., Ningbo Jinghe Electronic Tech Co Ltd, Beijing Zhongqi Huakang Tech Development Co. Ltd., among others.

Reasons to Purchase this Report

The Glucose Monitoring Devices Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of glucose monitoring devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in glucose monitoring devices.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the glucose monitoring devices patent landscape.

• Risk Assessment: In technology-intensive fields such as glucose monitoring devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Glucose Monitoring Devices Patent Landscape Report

• Who are the key players in the glucose monitoring devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in glucose monitoring device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the glucose monitoring devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in glucose monitoring devices?
• What are the challenges and opportunities in the glucose monitoring devices patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in glucose monitoring devices?

Related Reports

Glucose Monitoring Devices Market

Glucose Market

Blood Glucose Test Strip Market

Blood Glucose Meters Market